{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:18:18Z","timestamp":1773296298870,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1053\/j.seminoncol.2005.02.008","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:58:14Z","timestamp":1131026294000},"page":"S16-S22","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S2","title":["The evolving role of pemetrexed (Alimta) in lung cancer"],"prefix":"10.1053","volume":"32","author":[{"given":"Mark A.","family":"Socinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Stinchcombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Neil","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2005.02.008_bib1","series-title":"Cancer Facts and Figures","year":"2004"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib2","series-title":"Diagnosis and Treatment of Lung Cancer","first-page":"307","article-title":"Chemotherapy for stage IV non-small cell lung cancer","author":"Socinski","year":"2001"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2004.09.053","article-title":"American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline","volume":"22","author":"Pfister","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib4","series-title":"Diagnosis and Treatment of Lung Cancer","first-page":"360","article-title":"Extensive stage small cell lung cancer","author":"Gillenwater","year":"2001"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib6","doi-asserted-by":"crossref","first-page":"4276s","DOI":"10.1158\/1078-0432.CCR-040010","article-title":"Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent","volume":"10","author":"Adjei","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/14737140.3.2.145","article-title":"Pemetrexed (Alimta)","volume":"3","author":"Adjei","year":"2003","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib8","first-page":"545","article-title":"Homocysteine and methylmalonic acid","volume":"1","author":"Niyikiza","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib9","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1200\/JCO.1999.17.4.1194","article-title":"Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer","volume":"17","author":"Rusthoven","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/annonc\/mdf115","article-title":"Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer","volume":"13","author":"Clarke","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/annonc\/mdg099","article-title":"ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer","volume":"14","author":"Smit","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1008336931378","article-title":"Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin","volume":"11","author":"Manegold","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/1097-0142(20010801)92:3<595::AID-CNCR1359>3.0.CO;2-D","article-title":"Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma","volume":"92","author":"Shepherd","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib15","first-page":"631","article-title":"A phase II trial of pemetrexed (P) plus carboplatin (C) in patients (pts) with advanced non-small cell lung cancer (NSCLC)","volume":"23","author":"Koshy","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib16","first-page":"625","article-title":"Phase II randomized study of pemetrexed + carboplatin or oxaliplatin, as front-line chemotherapy in patients with locally advanced or metastatic non-small cell lung cancer","volume":"22","author":"Scagliotti","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib17","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.2000.18.8.1748","article-title":"Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors","volume":"18","author":"Adjei","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib18","first-page":"630","article-title":"Pemetrexed (Pem)\/gemcitabine (Gem) as front-line therapy for advanced NSCLC","volume":"23","author":"Adjei","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib19","first-page":"311a","article-title":"Phase II trial of pemetrexed + gemcitabine in patients with advanced non-small cell lung cancer","volume":"21","author":"Ettinger","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib20","first-page":"645","article-title":"Pemetrexed plus gemcitabine as front-line therapy for patients with advanced stage non-small lung cancer","volume":"23","author":"Treat","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"suppl 5","key":"10.1053\/j.seminoncol.2005.02.008_bib21","first-page":"149","article-title":"Phase II study of pemetrexed and vinorelbine in patients with locally advanced or metastatic non-small cell lung cancer","volume":"13","author":"Clarke","year":"2002","journal-title":"Ann Oncol"},{"issue":"suppl 6","key":"10.1053\/j.seminoncol.2005.02.008_bib22","first-page":"55","article-title":"MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma","volume":"26","author":"Teicher","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0360-3016(03)00595-9","article-title":"Radiosensitization by pemetrexed of human colon carcinoma cells in different cell cycle phases","volume":"57","author":"Bischof","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 2","key":"10.1053\/j.seminoncol.2005.02.008_bib24","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0169-5002(03)91966-0","article-title":"A phase I trial of pemetrexed + chest radiotherapy in patients with advanced or metastatic non-small cell lung cancer or esophageal cancer","volume":"41","author":"Vokes","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib25","first-page":"664","article-title":"Randomized phase II trial of pemetrexed with either cisplatin or carboplatin in extensive stage small cell lung cancer","volume":"23","author":"Socinski","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"suppl 2","key":"10.1053\/j.seminoncol.2005.02.008_bib26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.seminoncol.2005.02.007","article-title":"Pemetrexed (Alimta) in small cell lung cancer","volume":"32","author":"Socinski","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.008_bib27","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1200\/JCO.1997.15.10.3223","article-title":"Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin","volume":"15","author":"Leichman","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775405000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775405000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T04:48:09Z","timestamp":1554353289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775405000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":27,"alternative-id":["S0093775405000783"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2005.02.008","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}